The Immune Response to Stroke

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-06-24

Study Completion Date

2029-06-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Some patients develop cognitive decline after a stroke, but we don't always understand the mechanisms. It has been proposed that a proportion of the patients develop an autoimmune immune response, and that this could potentially explain the cognitive decline in some of the patients. The current study aims to investigate this hypothesis in a subgroup of patients with stroke.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Autoimmune Phenomena After Acute Stroke

NCT01082783

Stroke

COMPLETED

Stroke-induced Immunodepression in Neurorehabilitation

NCT05889169

Stroke Lymphopenia Immunosuppression

COMPLETED

Autoimmune Features of Neurodegenerative Disorders

NCT04239079

Parkinson Disease Alzheimer Disease Mild Cognitive Impairment

RECRUITING

The Predictive Value of Clinical and Immunological Factors in the Development of Pneumonia After Traumatic Brain Injury

NCT00929448

Traumatic Brain Injury

COMPLETED

Diagnostic Performance of a Commercial Assay for the Detection of Neuronal Antibodies

NCT05783947

Paraneoplastic Neurological Syndrome Autoimmune Encephalitis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke, Acute Dementia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stroke patients

Analysis of post-stroke immune responses

Intervention Type OTHER

Analysis of immune responses in peripheral blood

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Analysis of post-stroke immune responses

Analysis of immune responses in peripheral blood

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Stroke \< 72 h
* Age \> 18 years

Exclusion Criteria

* Brain hemorrhage verified by CT or MRI scan
* Previous or present immunological disease or other serious comorbidity
* Ongoing immune respons after infection or vaccination \< 1 month
* Cognitive without ability to understand and/or give an informed consent to participate in the study

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No